Expert Review of Pharmacoeconomics and Outcomes Research

Cost studies in clinical trials
pp. 591-594(4)
Authors: Shaya, Fadia T; Samant, Navendu

Formulary decision methodology in the context of health system costs and insurance trends
pp. 595-597(3)
Authors: Shaya, Fadia T; Samant, Navendu

Four quadrants of the cost-effectiveness plane: some considerations on the south-west quadrant
pp. 599-601(3)
Authors: Klok, Rogier M; Postma, Maarten J

News in Brief
pp. 603-608(6)

5th European Conference on Health Economics
pp. 611-612(2)
Author: Oliver, Adam

10th Annual Australian Health Outcomes Conference 2004: 10 years on and going strong
pp. 613-615(3)
Author: King, Madeleine

Cost effectiveness of leflunomide in the treatment of rheumatoid arthritis in Japan
pp. 617-622(6)
Authors: Suka, Machi; Yoshida, Katsumi

Cost effectiveness of methylphenidate versus AMP/DEX mixed salts for the first-line treatment of ADHD
pp. 625-634(10)
Authors: Narayan, Sangeeta; Hay, Joel

Estimating the cost effectiveness of alternative drug treatments for postmenopausal osteoporosis
pp. 637-644(8)
Author: Ohsfeldt, Robert L

Outcomes associated with inhaled corticosteroid use in asthma and COPD: an update
pp. 645-656(12)
Authors: Bhosle, Monali J; Shenolikar, Rahul A; Kulkarni, Amit S; Balkrishnan, Rajesh

Utility values for obesity and preliminary analysis of the Health Outcomes Data Repository
pp. 657-665(9)
Authors: Dixon, Simon; Currie, Craig J; McEwan, Phil

Interferon-αα in high-risk melanoma patients
pp. 667-676(10)
Authors: Cormier, Janice N; Xing, Yan; Ross, Merrick I; Cantor, Scott B